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List of abbreviations:  23 
PHT  = portal hypertension 
DALY  = disability adjusted life year 
PV  = portal vein 
IVC  = inferior vena cava 
HV = hepatic vein 
IHVR   = increased hepatic vascular resistance 
HA   = hepatic artery 
TAA  = thioacetamide 
VCC  = vascular corrosion casting 
DTM  = deep tissue microscopy 
µCT  = micro-CT 
AA   = abdominal aorta 
CVC   = caudal vena cava 
RML = right medial lobe 
IHC  = immunohistochemistry 
HVPG   = hepatic venous pressure gradient 
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Abstract 26 
Cirrhosis represents the end-stage of any persistent chronically active liver disease. It is 27 
characterized by the complete replacement of normal liver tissue by fibrosis, regenerative 28 
nodules, and complete fibrotic vascularized septa. The resulting angioarchitectural distortion 29 
contributes to an increasing intrahepatic vascular resistance, impeding liver perfusion and 30 
leading to portal hypertension.  31 
To date, knowledge on the dynamically evolving pathological changes of the hepatic 32 
vasculature during cirrhogenesis remains limited. More specifically, detailed anatomical data 33 
of the vascular adaptations during disease development is lacking. To address this need, we 34 
studied the 3D architecture of the hepatic vasculature during induction of cirrhogenesis in a rat 35 
model. Cirrhosis was chemically induced with thioacetamide. At predefined time points, the 36 
hepatic vasculature was fixed and visualized using a combination of vascular corrosion casting 37 
and deep tissue microscopy. 3D reconstruction and data fitting enabled extracting cirrhogenic 38 
features at multiple scales, portraying the impact of cirrhosis on the hepatic vasculature. At the 39 
macrolevel, we noticed that regenerative nodules severely compressed pliant venous vessels 40 
from 12-week thioacetamide intoxication onwards. Especially hepatic veins were highly 41 
affected by this compression, with collapsed vessel segments severely reducing perfusion 42 
capabilities. At the microlevel, we discovered zone-specific sinusoidal degeneration with 43 
sinusoids located near the surface being more affected than those in the middle of a liver lobe. 44 
Our data sheds light on and quantifies the evolving angioarchitecture during cirrhogenesis. 45 
These findings may prove helpful for future targeted invasive interventions.    46 
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Introduction 51 
Cirrhosis is the common end-point of any given progressive chronic active liver disease and 52 
can evolve to liver insufficiency and clinically significant portal hypertension (PHT) (Pinzani 53 
et al., 2011). PHT is responsible for the more severe and often lethal complications of cirrhosis 54 
such as bleeding oesophageal varices, ascites, renal dysfunction and hepatic encephalopathy. 55 
Because of the combined impact of these complications, PHT remains the most important cause 56 
of morbidity and mortality in patients with cirrhosis. Not surprisingly, cirrhosis therefore 57 
accounts for approximately 1.03 million deaths per year worldwide (Tsochatzis et al., 2014). 58 
Moreover, 31 million disability adjusted life years (DALYs), equivalent to 1.2% of the global 59 
DALY burden, are attributed to this chronic condition (Mokdad et al., 2014). 60 
Since the common pathway to cirrhosis entails repetitive destruction and regeneration of liver 61 
tissue, morphological characteristics of cirrhosis comprise diffuse fibrogenesis and the 62 
conversion of the normal liver architecture into structural abnormal regenerative nodules 63 
(Anthony et al., 1978).  64 
The morphological remodeling exerts a mechanical impact on each of the large hepatic venous 65 
vessels, as these pliant veins, i.e. the portal vein (PV), intrahepatic inferior vena cava (IVC) and 66 
hepatic veins (HVs) are highly amenable for mechanical compression (Levy AD, 2015, Ismail 67 
and Pinzani, 2009, Yamamoto et al., 1984). This architectural distortion contributes to an 68 
increased hepatic vascular resistance (IHVR) and is generally accountable for approximately 69 
70% of the increase in portal pressure in liver cirrhosis (Hu et al., 2013, Laleman et al., 2005). 70 
The morphological impact of cirrhosis is also conspicuous at the level of the hepatic 71 
microcirculation (Thabut and Shah, 2010). The microvascular phenotype is transformed from 72 
highly specialized porous sinusoids into continuous, more rigid capillaries, a process termed 73 
sinusoidal capillarization with a uniform defenestration of the endothelial cells and 74 
development of subendothelial basal membranes (Braet and Wisse, 2002, Huet et al., 1982). In 75 
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addition, cirrhosis causes numerous microscopic vessel aberrations. Hepatic arterial (HA), PV 76 
and HV vessels may tangle with each other. Various distorted spatial arrangements have been 77 
reported in blood vessels of cirrhotic livers, such as sharp bends, anomalous branching patterns, 78 
abnormal branching angles and tortuosity. Severe damage (characterised by bridging fibrosis) 79 
results in stenosis and eventually loss of vessels. In contrast, new vessels may originate to 80 
support the blood supply and venous drainage of the regenerative nodules. The resulting 81 
neovasculature is primarily located in the fibrotic regions which bypasses functional liver tissue 82 
and further aggravates liver insufficiency (Debbaut, 2013, Kline et al., 2014, Hano and 83 
Takasaki, 2003, Van Steenkiste, 2010, Vanheule et al., 2008). Furthermore, cirrhosis is 84 
considered the principal cause of intrahepatic portosystemic shunts (Lutz et al., 2004). 85 
However, the majority of portosystemic shunts observed in portal hypertension are 86 
extrahepatic, attempting to alleviate the raised portal pressure (Bodner et al., 2002, Alexander 87 
et al., 2001, Mori et al., 1987). Non-tumorous arterioportal shunts have been described in 88 
cirrhosis, as are portal-to-portal venous shunts, although the latter are considered rare (Bodner 89 
et al., 2002, Kassissia et al., 1994, Bhargava et al., 2011).  90 
Despite the irrefutable importance of the above described research, knowledge on the 91 
pathological alterations of the hepatic (micro)vasculature during the genesis of cirrhosis is 92 
scanty. In this context, animal models are valuable tools to analyze this disease process in the 93 
most appropriate way. The thioacetamide (TAA) model is a reproducible model of homogenous 94 
and macronodular cirrhosis, associated with all the typical features of cirrhosis, including PHT 95 
and a hyperdynamic circulatory state (Laleman et al., 2006).  96 
We aimed at measuring the morphological changes of the hepatic vasculature at different time 97 
points during the TAA-induced cirrhogenesis. Detailed anatomical data of rat livers was 98 
obtained using two complementary, recently optimized techniques, namely vascular corrosion 99 
casting (VCC) and deep tissue microscopy (DTM) after immunofluorescence staining (Peeters 100 
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et al., 2017). A quantitative description of the spatiotemporal impact of cirrhosis on the hepatic 101 
vasculature may facilitate a better understanding of the underlying mechanisms, contributing to 102 
the increasing IHVR which eventually leads to complications such as PHT (Laleman et al., 103 
2006).   104 
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Materials and methods 105 
A. Animals  106 
Cirrhogenesis was induced by oral administration of TAA (Sigma-Aldrich, Bornem, Belgium). 107 
Prolonged TAA intoxication causes a stepwise process toward compensated cirrhosis (Laleman 108 
et al., 2006). At the start of the protocol, 0.03% TAA concentration was added to the drinking 109 
water. Thereafter, TAA concentrations were weekly adapted to keep individual body weights 110 
within the limits of 250 - 300g.  111 
Male Wistar rats (n = 38) were randomly divided into 4 groups. Each group consisted of 9 112 
animals, except for the fourth group where 2 extra animals were allocated to accommodate 113 
potential mortality. The animals were kept in cages at a constant temperature and humidity in 114 
a 12h controlled light/dark cycle, with food and water provided ad libitum. Group 1 served as 115 
control group, allowing the baseline description of normal hepatic characteristics. Groups 2 to 116 
4 underwent TAA intoxication for 6, 12 and 18 weeks, respectively. After 6 weeks of 117 
administration, histopathological characteristics corresponded to steatohepatitis with 118 
significant fibrosis. At 12 weeks, the advanced fibrotic stage was attained and eventually, after 119 
18 weeks of intoxication, animals showed homogeneous macronodular cirrhosis (Laleman et 120 
al., 2006).  121 
At the different time points (0, 6, 12 and 18 weeks), the corresponding group (1-4, respectively) 122 
was sacrificed. Five animals of each group (6 in case of group 4) were assigned to the 123 
combination of VCC and micro-CT (µCT) imaging to study the macrocirculation. Four animals 124 
(5 in case of group 4) were allocated to DTM after immunofluorescence staining to capture the 125 
microcirculation.  126 
B. Vascular corrosion casting 127 
The procedure started with anaesthesia by intraperitoneal injection of 130µl/100g pentobarbital 128 
(Nembutal, Ceva Sante Animale, Brussels, Belgium) and careful exposure of the liver and 129 
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surrounding vessels. Anticoagulation was performed through intrasplenic administration of 130 
heparin (0.3 ml; 5000u/ml) (Heparine Leo, Leo Pharma, Lier, Belgium). The PV and abdominal 131 
aorta (AA) were injected sequentially and manually with 30 ml and 20 ml of a polyurethane-132 
based casting resin, respectively. The resin mixture consisted of PU4ii (VasQtec, Zurich, 133 
Switzerland), hardener (VasQtec, Zurich, Switzerland), ethyl methyl ketone (EMK; Merckx, 134 
Darmstadt, Germany) and color dyes (yellow and blue for the HA and PV system, respectively). 135 
The radiocontrast agent Lipiodol (Guerbet, Roissy-CdG, France) was added to the AA resin to 136 
allow a clear distinction between the venous and arterial vascular trees on µCT images. The 137 
thoracic aorta and renal arteries were clamped prior to infusion to direct the resin flow. 138 
Immediately after injection, the thoracic caudal vena cava (CVC) and both inlet vessels were 139 
clamped to prevent resin leakage. The specimen was allowed to polymerize for 72 hours. 140 
Afterwards, the liver tissue was macerated in potassium hydroxide (25% KOH) for 141 
approximately 5 days. The resulting cast was then scanned with X-ray imaging at a resolution 142 
of 40 µm using an in-house developed high-resolution µCT scanner (HECTOR, Centre for X-143 
ray Tomography (UGCT), Ghent University, Belgium). A more elaborate description of the 144 
VCC and µCT protocol was described earlier (Peeters et al., 2017). 145 
C. Deep tissue microscopy  146 
Animals were anaesthetized by intraperitoneal injection of 130µl/100g pentobarbital 147 
(Nembutal, Ceva Sante Animale, Brussels, Belgium) and subsequently underwent perfusion 148 
fixation with 4% phosphate-buffered paraformaldehyde. The liver was excised and cut into 350 149 
µm thick slices by means of a vibratome (Microm HM650V; Thermo Scientific, Massachusetts, 150 
USA). Slices from the top (up to 2 mm from the surface) and mid (4 – 6 mm from the surface) 151 
region of the right medial lobe (RML) were selected for further processing. The obtained slices 152 
were permeabilized following a protocol adapted from Renier et al. (Renier et al., 2014). After 153 
permeabilization, the samples were immunostained using a generic endothelial marker antibody 154 
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(RECA-1; Serotec, Kidlington, UK). The limited antibody penetration and imaging depth 155 
inherent to traditional immunohistochemistry (IHC) was tackled by applying an adapted version 156 
of the CUBIC (clear, unobstructed brain imaging cocktails and computational analysis) clearing 157 
protocol after IHC (Susaki et al., 2014). Subsequent confocal laser scanning (Nikon A1R; 158 
Nikon, Tokyo, Japan) using a 40x Plan Fluor air lens with extra-long working distance 159 
(numerical aperture 0.6; working distance 3.6-2.8 mm; Nikon Instruments, Paris, France) 160 
provided detailed volumetric datasets of the microcirculation (voxel resolution of (0.63 x 0.63 161 
x 1.4) µm3). The datasets were further processed and analyzed using in-house developed 162 
software. For more elaborate details on the DTM protocol, the reader is referred to (Peeters et 163 
al., 2017). 164 
D. Data analysis of the macrocirculation 165 
The µCT datasets were processed using the commercial software package Mimics (Materialise, 166 
Leuven, Belgium). Vascular trees (HA, PV and HV) were semi-automatically segmented as 167 
their grey value ranges differed in the µCT images. The arterially added contrast agent allowed 168 
distinguishing the PV from the HA system, and also assigned a different grey value range to 169 
the HV system due to mixing of the injected AA (with contrast agent) and PV resin. After 170 
segmentation, centerlines of the vascular trees were calculated and converted to graph structures 171 
using in-house developed software, which is based on TiQuant (Peeters et al., 2017, Friebel et 172 
al., 2015, Hammad et al., 2014). These graphs were used to quantify the branching topology 173 
and geometrical attributes (branch radius, length and number of vessels). A diameter-defined 174 
top-down ordering method was implemented, partially based on the method used by Jiang et al. 175 
(Jiang et al., 1994), to assign generation numbers to the different branches. As opposed to Jiang, 176 
inlets of each vascular tree (HA, PV and HV) were assigned generation “1” and daughter 177 
branches were allocated generation numbers higher than (or equal) to their parent vessel 178 
(Peeters et al., 2017). After data classification, exponential trend lines were fitted to the 179 
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morphological features (radius, length, number of vessels) as a function of their generation 180 
number. The fitting principle was similar to previous studies (Debbaut et al., 2012, Debbaut et 181 
al., 2014), and allowed quantifying the cirrhogenic evolution of the parameters studied. 182 
Regarding the number of vessels for each generation, trend lines were fitted based on the first 183 
4 generations of the PV and HV (and 3 in case of HA) and then further extrapolated. In this 184 
way, an inaccuracy of the number of vessels due to under-segmentation was limited.  185 
E. Data analysis of the microcirculation 186 
Prior to microvascular segmentation, DTM datasets were post-processed to reduce lipofuscin-187 
like autofluorescence, which was abundantly present from 12 weeks of TAA administration 188 
onwards. Practically, autofluorescence was separately recorded for every sample. The resulting 189 
autofluorescence signal was subsequently subtracted from the signal of the vasculature. In 190 
addition, we applied contrast enhancement, denoising and deconvolution  to eliminate imaging 191 
noise and reattribute out-of-focus components (Schindelin et al., 2012, Luisier et al., 2011).  192 
Segmentation of the microcirculation was executed automatically using in-house developed 193 
software. The segmented datasets allowed for accurate 3D reconstructions of the intertwined 194 
and interconnected blood vessels. Centerlines were calculated for each vessel to extract and 195 
quantify various morphological parameters. The radius was measured using a best-fit diameter 196 
approach, which was achieved by measuring the radius in 8 radially evenly distributed 197 
directions. By averaging over the 8 radii, the best-fit radius was able to account for the 198 
ellipsoidal character of blood vessels. Branch lengths were calculated as the cumulative 199 
distance between vessel intersections. The tortuosity of a branch was defined as the ratio of the 200 
total branch length to the distance between the start and end point of the branch. The 3D porosity 201 
of the vascular network was calculated as the total vascular volume divided by the volume of 202 
its envelope. More information on the segmentation and analysis pipeline can be found in 203 
(Peeters et al., 2017).  204 
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Statistical analyses were performed in R (open source language). Non-parametric Kruskal-205 
Wallis tests were executed with Holm-Bonferroni adjustment to assess the sinusoidal 206 
remodeling during cirrhogenesis. Differences with a p-value below 0.05 were considered 207 
statistically significant. Post hoc pairwise multiple comparison used the Conover-Iman test, 208 
which is robust for small sample sizes.   209 
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Results 210 
As illustrated by Fig. 1A-B, rat livers were excised and casted at different time points during 211 
cirrhogenesis. The macroscopic expression of the liver clearly evolved from normal over an 212 
irregular ‘salt & pepper’-like appearance (6 weeks) to an emerging nodular (12 weeks) and 213 
eventually macronodular liver at 18 weeks. These changing appearances were accurately 214 
captured by the casting procedure, as nodules appeared at the liver’s surface from 12 weeks 215 
onwards.  216 
A. Macrocirculation 217 
Cirrhosis affects mainly the hepatic venous vessels 218 
For each time point, two liver casts were processed down to a 3D reconstruction of all vascular 219 
trees (HA, PV, and HV) (Fig. 1C-E). From 12-week intoxication onwards, regenerative nodules 220 
started to mechanically compress their surroundings, which aggravated due to their 221 
continuously growing dimensions. The pliant HV branches were largely affected by this 222 
mechanical compression, and even appeared to collapse as evidenced from the scanned casts 223 
(Fig. 2A). In the cirrhotic stage, the PV system was also affected by the nodular compression, 224 
albeit to a lesser extent, and several portosystemic shunt vessels were detected, connecting the 225 
trunk of PV with the CVC (Fig. 2B, color-coded in magenta). Furthermore, we observed that 226 
HA branches became more tortuous due to cirrhosis as sudden sharp bends appeared which 227 
were not observed in the control group. However, the HA cross-sections remained unaffected 228 
by the nodular compression, most likely because arterial vessel walls include a thick muscle 229 
layer (Fig. 2C).   230 
Regenerative nodules mechanically compress the hepatic venous trees 231 
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The vascular trees were classified according to their diameter-defined branching topology. For 232 
each generation, the mean radius, length and number of vessels were measured (Fig. 3). Due to 233 
the restricted µCT resolution, fewer blood vessel generations were measured for the HA 234 
systems, as HA branches normally have smaller diameters than venous branches.  235 
At the 6-week time point, all vascular trees (HA, PV, HV) appeared unaffected as their 236 
morphological parameters (radii, length, and number vessels) were comparable to control 237 
values. From the 12-week time point, when regenerative nodules began to grow in expansive 238 
manner, radii of the HV gradually decreased. Illustrative is the significant decline of the CVC 239 
radius, dropping from 3.01 mm (healthy) to 1.39 mm (most severe case of cirrhosis) (see 240 
supplementary material Table 1).  241 
The PV system was less affected by cirrhosis. The PV inlet radius marginally dilated from 1.28 242 
mm (rat 1 and 2) to 1.71 mm (rat 7) with increasing intoxication time. However, in rat 8 243 
(presumably a more advanced cirrhotic stage), the PV inlet radius narrowed to 1.01 mm (shown 244 
in supplementary material Table 2). Moreover, a clear widening of the arterial tree was 245 
measured during cirrhogenesis, as the HA inlet radius dilated from 1.71 x 10-1 mm (rat 2) to 246 
3.01 x 10-1 mm (rat 7) (depicted in supplementary material Table 3).  247 
We did not observe any trends in the progression of cirrhogenesis for the number of vessels and 248 
length in function of the generation number. The mean lengths did not even show clear-cut 249 
declining trends in the first generation(s), but started to decrease in higher generations. In 250 
addition, the length of the first generation was underestimated as it was partially cut during 251 
resection of the liver. Therefore, the length of the first generation was not considered when 252 
fitting the trend lines in Fig. 3B.     253 
  254 
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B. Microcirculation   255 
Cirrhogenesis instigates remodeling of the microcirculation 256 
For each time point, ten to maximally thirteen DTM samples (randomly selected from four 257 
livers with a minimum of two samples/liver) were post-processed, 3D reconstructed and 258 
subjected to pairwise comparison (Fig. 4A-B). For the 12-week and 18-week samples, we 259 
differentiated between sinusoids in regenerative nodules and shunt vessels in the fibrotic septa, 260 
both constituting the microcirculation. This was achieved by pre-imaging the slices at a lower 261 
resolution (2.48 µm; x10 magnification), allowing visual recognition of nodules and 262 
vascularized septa. Samples of their respective microcirculation were subsequently gathered by 263 
scanning both structures individually at a higher resolution (0.63 µm; x40 magnification).       264 
Histograms of the sinusoidal radii during disease progression are displayed in Fig. 4C. The 265 
mean radius decreased from 4.45 ± 0.23 µm in the control animals to 3.87 ± 0.47 µm at week 266 
18 (p = 0.0047). In addition, the porosity (i.e. the sinusoidal volume per unit of volume) steadily 267 
declined from 20.43 ± 1.92% (control) to 11.12 ± 3.06% (week 18) (p < 10-8) (see Fig. 4D). 268 
The sinusoidal tortuosity and length increased slightly but significantly (p < 10-5) during 269 
cirrhogenesis going from 1.12 ± 0.01 to 1.19 ± 0.05 and 18.67 ± 0.83 µm to 23.95 ± 4.39 µm, 270 
respectively from week 0 to week 18 (see Fig. 5).  271 
Cirrhosis affects the sinusoidal network zone-specifically 272 
Samples sectioned near the top (n >= 5) were compared to samples located in the middle of the 273 
RML (n >= 5). We found that sinusoids situated in the core of the lobe typically had larger radii 274 
and appeared less affected by the cirrhogenic process compared to those near the surface (Fig. 275 
6). Pairwise comparison of the 18-week samples demonstrated significantly different radii in 276 
these 2 zones (p = 0.048). Variations between the porosity of mid- and top-located samples 277 
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existed, but did not vary significantly. Similar observations were made for the branch length 278 
and tortuosity. 279 
Cirrhosis is characterized by the formation of highly vascularized fibrous septa  280 
We analyzed several samples consisting primarily of vascular septa in case of cirrhosis (n=3) 281 
and compared their radial histogram with those of cirrhotic sinusoids (Fig. 4D). The skewed 282 
distribution of the vascular septa indicated the presence of very large blood vessels (radius > 283 
10 µm) acting as intrahepatic shunts. The septa also comprised a substantial amount of smaller 284 
intertwined blood vessels, which probably originated to support blood supply. Both vessel types 285 
are embedded in fibrotic tissue and thus separated from the hepatocytes. They act as bypasses 286 
guiding the blood flow directly from the portal tract into the central vein.    287 
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Discussion 288 
The present study is, to the best of our knowledge, the first to analyze the main remodeling 289 
events of the hepatic vascular architecture during TAA cirrhogenesis in rat. Solely using static 290 
techniques (VCC and DTM), we were able to study and quantify the dynamic transition of this 291 
pathological process. At 4 discrete time points during the progression toward cirrhosis, VCC 292 
and DTM were used to capture, 3D reconstruct and morphologically analyze the intricate 293 
hepatic vasculature across multiple length scales. Our data demonstrated various anatomical 294 
abnormalities attributable to cirrhosis, which are likely to underlie the increase of total IHVR 295 
as previously characterized hemodynamically in this model and at the same given time points 296 
(Laleman et al., 2006).    297 
With VCC, we examined the circulatory changes at the macrolevel. From 12-week TAA 298 
intoxication onwards, regenerative nodules started to grow in an expansive manner. It is 299 
commonly assumed that this tissue growth exerts a compressive force on the surrounding blood 300 
vessels (Fig. 2). This compression narrowed the pliant venous systems (PV and HV), but we 301 
found that especially HVs were highly impacted by this compression, with collapsed vessel 302 
segments severely impeding hepatic outflow (Fig. 3). The mean diameters of the HV across the 303 
first generations nearly halved. As resistance of a vessel scales inversely with its radius to the 304 
fourth power following Poiseuille’s law, it is not surprising that an increase of the total IHVR 305 
was documented in TAA-induced cirrhotic livers (Laleman et al., 2006).  306 
Furthermore, the HA dilated with increasing intoxication time. The diameter of the PV most 307 
likely increased up until the moment the mechanical impact of the regenerative nodules 308 
outweighed the internal portal pressure and forced the PV to narrow, as observed in rat 8 (more 309 
advanced stage of cirrhosis). Progressive narrowing of the HV and PV vasculature contributed 310 
to the ever-increasing IHVR and hepatic venous pressure gradient (HVPG) over the liver in 311 
cirrhosis (Laleman et al., 2006).  312 
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At the microscopic level, sinusoidal remodeling was abundantly present. Capillarization and 313 
the impaired intrahepatic balance between vasodilators and -constrictor presumably caused the 314 
diameters and number of sinusoids to decrease (Thabut and Shah, 2010). We observed that, 315 
from 12 weeks onwards, the microvascular porosity and sinusoidal radii differed significantly 316 
from control data at week 0 (Fig. 4C and Fig. 5A-B). Even though macrocirculatory changes 317 
were still limited, PHT was already measured at 12 weeks as document earlier in the animal 318 
model (Laleman et al., 2006). This suggests that the increase of the IHVR is initiated at the 319 
microlevel and is further aggravated by alterations at the macroscale later on. At 18 weeks, PHT 320 
became associated with a hyperdynamic circulatory state (another pathophysiological hallmark 321 
of cirrhosis), which may have further contributed to the increasing portal pressure (Laleman et 322 
al., 2006).   323 
At 18 weeks of TAA intoxication, the presence of complete fibrous vascularized septa was 324 
previously reported (Laleman et al., 2006). In the present work, we observed that these portal-325 
portal and portal-central septa, encapsulating regenerative nodules, comprised a considerable 326 
amount of small vessels as well as larger intrahepatic shunt vessels (Fig. 4C). Additionally, 327 
intrahepatic portosystemic shunts were detected between the trunk of the PV and CVC (Fig. 328 
2C). These shunt vessels most likely developed in an attempt to alleviate the elevated portal 329 
pressures, but at the cost of shunting large amounts of blood directly into the systemic 330 
circulation without contact with the hepatocytes, incapacitating as such synthetic and 331 
detoxification liver functions.  332 
Although the workflow of this study is straightforward, some aspects are very labor intensive 333 
and time consuming. This is particularly the case for the segmentation of the µCT datasets of 334 
the vascular corrosion casts, which is why only two liver casts were fully segmented for each 335 
cirrhogenic stage. Therefore, it is necessary to consider the reported numerical data as 336 
indicative. Moreover, liver casts should ideally be µCT-scanned at a sufficiently high resolution 337 
18 
 
to allow reconstructing the HA accurately up to the same generation as the PV. Since diameters 338 
of HA branches are typically smaller than PV branches, this was technically impossible with 339 
the current computational capabilities. As a consequence, the number of HA vessels for each 340 
generation was underestimated as smaller ramifying branches remained undetected. Since the 341 
HA runs in parallel with the PV, we can only assume that the number of vessels should be at 342 
least equal to or even higher (due to PV being flanked by more than one parallel HA vessels) 343 
than the PV (Debbaut et al., 2014).       344 
The hypothesis that the casting resin caused significant tissue shrinkage was discredited. We 345 
presumed that the known shrinkage of the cast resin was compensated by the pressure exerted 346 
during the injection of the polymer (Debbaut et al., 2014, Krucker et al., 2006, Meyer et al., 347 
2007).  348 
 349 
Conclusion 350 
Cirrhotic changes of the hepatic vasculature were analyzed and quantified in the TAA cirrhotic 351 
rat model. At predefined time points, two techniques (VCC and DTM) were used to accurately 352 
capture and 3D reconstruct the hepatic vasculature across different scales, ranging from the 353 
largest blood vessels down to the sinusoids. Their complementarity allowed to provide a 354 
comprehensive overview of the impact of cirrhosis on the vasculature, revealing static 355 
mechanisms behind the increased IHVR which were hemodynamically characterized earlier at 356 
similar time points and in the same model  (Laleman et al., 2006). The combined impact of this 357 
work, both hemodynamically as angioarchitecturally, might be of interest for targeted liver 358 
interventions both pharmaceutically, surgically and angiographically.  359 
 360 
  361 
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Figures 447 
 448 
Fig. 1. A. Rat livers were excised at different time points during cirrhogenesis. The right medial 449 
lobe (RML) was sectioned prior to immunostaining. The macroscopic expression of the liver 450 
transformed from normal over an irregular ‘salt & pepper’-like appearance at 6 weeks to an 451 
emerging nodular liver at 12 weeks and ultimately macronodular liver at 18 weeks. B. Vascular 452 
replicas obtained using vascular corrosion casting (VCC). Blue pigmented resin was injected 453 
via the PV and yellow dye was added to the arterial resin. C-E. 3D reconstructions of the 454 
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mascroscopic hepatic veins (HV), portal veins (PV) and hepatic arteries (HA), respectively, 455 
obtained using VCC.  456 
 457 
Fig. 2 Accurate 3D reconstruction of the macrocirculation of a cirrhotic liver (18 weeks). A. 458 
The amendable hepatic veins (HV) in the medial lobe are significantly compressed by 459 
regenerative nodules and some branches even appeared to collapse. B. Porto-systemic shunts 460 
(arrows) were detected, shunting directly from the root of the PV into the HV (CVC). Branching 461 
trees from the PV and HV were cut and the view was rotated to visualize the shunts. C. Due to 462 
cirrhosis, arterial branches became more tortuous, resulting in sudden sharp bends (arrows).   463 
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 464 
Fig. 3 The macrovascular trees – hepatic vein (HV), portal vein (PV), and hepatic artery (HA) 465 
– were classified according to their diameter-defined branching topology. For each liver 466 
intoxicated with TAA during different weeks (0w, 6w, 12w, 18w), the mean radius (A), length 467 
(B), and  number of vessels (C) were measured as function of the generation number and 468 
exponential trend lines were fitted. Due to mechanical compression of the nodules, cirrhosis 469 
appeared to have a high impact on the radius of the HV.   470 
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 471 
Fig. 4. A. Example of a stack of 2D images acquired through deep tissue microscopy (DTM). 472 
B. The dataset was automatically processed to segment the sinusoidal network and convert it to 473 
a graph. Here, the network graph is colored according to the mean radius of the branches. The 474 
graph allowed extracting other morphological parameters, including the length, tortuosity and 475 
porosity. C. Histograms of the sinusoidal radii during the different cirrhogenic stages. The 476 
values visibly shift to the left, when progressing from a normal to a cirrhotic liver. At 12 weeks 477 
and 18 weeks, we differentiated between the sinusoids in regenerative nodules and the 478 
microvascular vessels in the vascular septa. These vascular septa consisted of a substantial 479 
number of smaller vessels, but also a considerable number of large shunt vessels (diameter > 480 
10 µm). D. 3D reconstructions of the intricate sinusoidal network obtained with DTM (140 µm 481 
thick samples). The volume of blood vessels per volume unit (=porosity) decreased with 482 
increasing intoxication time from 19% (normal) over 16% (significant fibrosis) and 9% 483 
(advanced fibrosis) to 7% (cirrhosis).        484 
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 485 
Fig. 5 Boxplots for the radius (A), porosity (B), branch length (C), and tortuosity (D) of the 486 
microcirculation in function of TAA intoxication time. The radius and porosity differed 487 
significantly between normal and cirrhotic livers (p<0.05). Both parameters decreased 488 
gradually during cirrhogenic progression, contributing to the increased intrahepatic vascular 489 
resistance.    490 
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 491 
 492 
Fig. 6 Boxplots for the radius (A), porosity (B), branch length (C), and tortuosity (D) of the 493 
microcirculation as a function of TAA intoxication time and location within the lobe.  Slices 494 
(350 µm) were taken near the top (up to 2 mm from the surface) and mid (4 – 6 mm from the 495 
surface) region of the right medial lobe (RML). Sinusoids situated in the core of the lobe 496 
appeared to be less affected by the cirrhogenic process, as their mean radii and porosity were 497 
typically larger than those near the surface. When comparing the 18-week intoxicated samples 498 
pairwise, the radii even differed significantly between the top and mid region (p = 0.048). 499 
